Fundraising Fox
Halda Therapeutics
New Haven, US · Founded 2018 · Delaware LLC · 39,024 employees on LinkedIn · 8 known investors
Find your way into Halda Therapeutics
Sign up to find every way you can get introduced to Halda Therapeutics
- Your email: who you already know at Halda Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Halda Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Board
Investors · 8
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Canaan Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · Not right? Tell us
How we know: Elm Street Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Vida Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$197.9M disclosed across 4 rounds · 2019–2024
▶$126.5MraisedAug 2024 · 20 investors · Other Health CareRule 506(b)
- Liam RatcliffeDirector
- Nandita ShangariDirector
- Tim ShannonExecutive Officer, Director
- Joe CabralDirector
- Rebecca FreyDirector
- Rebecca LuseDirector
- Arjun GoyalDirector
- Scott PhillipsExecutive Officer
- Offering amount
- $126.5M
- Amount sold
- $126.5M
- First sale
- Jul 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedMay 2024 · 9 investors · Other Health CareRule 506(b)
- Liam RatcliffeDirector
- Rebecca FreyDirector
- Tim ShannonExecutive Officer, Director
- Scott PhillipsExecutive Officer
- Offering amount
- $36M
- Amount sold
- $24.2M
- First sale
- May 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$41MraisedDec 2021 · 11 investors · BiotechnologyRule 506(b)
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Liam RatcliffeDirector
- Leyi WangDirector
- Rebecca FreyDirector
- Offering amount
- $51M
- Amount sold
- $41M
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$6.3MraisedMar 2019 · 12 investors · Other Health CareRule 506(b)
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Wei ZhaoDirector
- Offering amount
- $25.1M
- Amount sold
- $6.3M
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Halda Therapeutics went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Halda Therapeutics.
In the news
Frequently asked questions
- Who are Halda Therapeutics's investors?
- Halda Therapeutics's investors include Access Biotechnology, Canaan Partners, Connecticut Innovations, Elm Street Ventures, Frazier Life Sciences, RA Capital, Taiho Ventures, LLC, Vida Ventures.
- How much funding has Halda Therapeutics raised?
- Halda Therapeutics has disclosed $197.9M raised across 4 rounds.
- Where is Halda Therapeutics headquartered?
- Halda Therapeutics is headquartered in New Haven, US.